Skip to content

HCG orders shipping delayed. Free shipping on orders $150+. Same-day dispatch on other items before 2pm ET

BPC-157 Research: What the Preclinical Studies Cover

What BPC-157 is, where its sequence comes from, and what preclinical research has studied: tendon and ligament repair, gut mucosa, angiogenesis and nitric-oxide signaling.

3 min readDarkside Labs Research Team
Darkside Labs BPC-157 10 mg research vial with a blue cap on a dark reflective surface

BPC-157 is one of the most discussed research peptides, and one of the most misunderstood. Much of what is written about it online runs well ahead of the evidence. This is a plain summary of what the compound is and what published research has actually looked at.

What BPC-157 is

BPC-157 stands for Body Protection Compound 157. It is a synthetic pentadecapeptide, 15 amino acids long, with the sequence GEPPPGKPADDAGLV. The sequence is a fragment of a larger protein first described in human gastric juice.

  • Molecular formula: C62H98N16O22
  • Molecular weight: about 1419.5 g/mol
  • CAS number: 137525-51-0

One property sets it apart from most short peptides: it is reported to stay stable in gastric juice for long periods, where peptides of similar size are usually broken down quickly. That stability is one reason it has been studied so widely in gastrointestinal models.

What preclinical research has looked at

Nearly all BPC-157 literature comes from cell culture and animal models, and a large share comes from a single research group at the University of Zagreb. That matters when weighing it: independent replication is thinner than the number of papers suggests.

Tendon, ligament and muscle

Rodent studies have examined BPC-157 in transected Achilles tendon, medial collateral ligament and muscle injury models, reporting differences in biomechanical and histological measures of healing. In vitro, tendon fibroblast studies have looked at outgrowth, cell survival under oxidative stress and migration, and some work reports increased growth hormone receptor expression in tendon fibroblasts.

Gastrointestinal mucosa

Given its origin, the gut was the first area studied. Animal models have looked at gastric ulcers, inflammatory bowel lesions, fistulas and anastomosis healing, and at protection against NSAID-induced lesions.

Angiogenesis and nitric oxide

A recurring theme is blood-vessel formation. Studies report effects on VEGFR2 expression and endothelial tube formation, and several papers describe interactions with the nitric-oxide system. These pathways are often proposed as the common thread behind results in very different tissues.

What the research does not show

There are very few published human studies, and none that establish safety or efficacy. BPC-157 is not an approved drug in the United States, and the FDA has listed it among bulk substances that raise significant safety concerns in compounding. It is also named on the World Anti-Doping Agency prohibited list.

For a lab, that means BPC-157 is a research tool with a large but narrow evidence base, not a characterised therapeutic.

Working with BPC-157 in the lab

BPC-157 is supplied as a lyophilized powder.

  • Storage: keep sealed vials at −20 °C, dry and away from light. See the peptide storage guide.
  • Reconstitution: bacteriostatic water is the standard multi-draw diluent. Add it slowly down the inside of the vial and swirl rather than shake. The reconstitution guide covers the bench steps.
  • Verification: with a sequence this short, mass spectrometry is a clean identity check, and the observed mass should match about 1419.5 Da. See how to read a certificate of analysis.

BPC-157 and TB-500

BPC-157 is often studied alongside TB-500, a peptide based on thymosin β4. The two are proposed to act through different mechanisms: angiogenesis and growth-factor signalling for BPC-157, actin dynamics and cell migration for thymosin β4. That difference is why some labs study them side by side.

Where to get it

Darkside Labs supplies BPC-157 10 mg as a lyophilized powder, and every batch is third-party tested.

Research use only. Nothing on this site is intended for human or veterinary use.

Frequently asked questions

What is BPC-157?

A synthetic 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV, derived from a protein found in human gastric juice. Its molecular weight is about 1419.5 g/mol.

Is BPC-157 an approved drug?

No. BPC-157 is not approved in the United States, published human data are very limited, and it is supplied by Darkside Labs only as a laboratory research material.

What has BPC-157 been studied for?

Mostly in cell and animal models: tendon, ligament and muscle repair, gastrointestinal mucosal integrity, angiogenesis and nitric-oxide signalling.

How should BPC-157 be stored?

Sealed lyophilized vials at −20 °C, dry and protected from light. After reconstitution, keep it at 2–8 °C and freeze single-use aliquots for longer storage.

  • bpc-157
  • tb-500
  • tissue repair
  • angiogenesis
  • preclinical research
Research use only:Not for human or veterinary use. Not a drug, food, cosmetic or dietary supplement. Must be handled by qualified professionals.

Keep reading